CardioLeaf

Chemistry helped Clearbridge Vitalsigns to transform a heart monitoring technology into an exceptional consumerfriendly product. It resulted in the world’s thinnest fully-intergrated 3-lead ECG device. We focused on key needs and concerns to come up with an original solution to create a product that would be attractive, friendly and comfortable
to use. The Cardioleaf was unveiled at the end of 2012 at the Medica fair in Dusseldorf, Germany. We not only helped in the design of the product but worked with Clearbridge to articulate the positioning of the product across 3 different offerings. Clearbridge is working intensively to bring the product on the market by the end of 2013.